BPC-157 Cost: What You Need to Know
US$ 20.31
melanotic neuroectodermal tumor of infancy pathology Melanotic neuroectodermal tumor of infancy:
Description
The target protein is engineered with a sortase-recognition motif (LPXTG) at the place where modification is desired
Currently the FDA website only has label information for Lopid, so its FDA indications are presented here
It has been widely studied in laboratory settings for its interaction with melanocortin receptors, particularly those involved in pigmentation pathways and receptor-mediated cellular signalling
Clin Exp Pharmacol Physiol (2001) 28:559
